5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer Journal Article


Authors: Zammarchi, F.; Boutsalis, G.; Cartegni, L.
Article Title: 5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer
Abstract: ERG, a member of the ETS transcription factor family, is frequently overexpressed in prostate cancer as a result of its fusion to the androgen-responsive Tmprss2 gene. Different genomic rearrangements and alternative splicing events around the junction region lead to multiple combination of Tmprss2:ERG fusion transcripts that correlate with different tumor aggressiveness, but their specific functions and biological activities are still unclear. The complexity of ERG expression pattern is compounded by the use of alternative promoters, splice sites, polyadenylation sites and translation initiation sites in both the native and fusion contexts. Our systematic characterization of native ERG and Tmprss2:ERG variants reveals that their different oncogenic potential is impacted by the status of the Ets domain and the configuration of the 5′ UTR region. In particular, expression and activity of functional ERG and Tmprss2:ERG variants are influenced both by translation initiation signals within the different isoforms and by inhibitory upstream Open Reading Frames (uORF) in their 5′ UTRs. Stable expression of ERG and Tmprss2:ERG variants promoted cell migration/invasion, induced a block of proliferation and induced a senescence-like state, suggesting a role for these variants in the prostate tumorigenesis process. In addition to Tmprss2:ERG fusion products, a group of related native ERG isoforms is also highly over-expressed in fusion-carrying prostate cancers, and share the same translation initiation site (in ERG exon 4) with the commonly observed Tmprss2 exon1 joined to ERG exon 4 (T1:E4) fusion-derived variant. Usage of this ATG can be preferentially down-regulated by directed antisense-based compounds, possibly representing the basis of a targeted approach that distinguishes between tumor-associated and normal ERG. © 2013 Zammarchi et al.
Journal Title: PLoS ONE
Volume: 8
Issue: 3
ISSN: 1932-6203
Publisher: Public Library of Science  
Date Published: 2013-01-01
Start Page: e49721
Language: English
DOI: 10.1371/journal.pone.0049721
PROVIDER: scopus
PMCID: PMC3589450
PUBMED: 23472063
DOI/URL:
Notes: --- - "Export Date: 1 April 2013" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors